Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$11,203,876
+$3,992,880 QoQ
Shares Held
9,341
+19.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#1,196
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEAVELL INVESTMENT MANAGEMENT, INC. holds $56,783,148 across 9 Drug Manufacturers - General names. LLY ranks #2 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,935 | $18,856,643 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
9,341 | $11,203,876 | |
| 3 | JNJ |
Johnson & Johnson
|
40,591 | $10,308,896 | |
| 4 | AMGN |
Amgen Inc
|
17,935 | $6,494,622 | |
| 5 | MRK |
Merck & Co., Inc.
|
41,794 | $5,370,529 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,579 | $2,107,681 | |
| 7 | AZN |
Astrazeneca PLC
|
6,562 | $1,244,286 | |
| 8 | PFE |
Pfizer Inc
|
35,669 | $858,909 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,203,876 | 9,341 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $7,210,996 | 7,840 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,277,186 | 7,702 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,964,371 | 7,817 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $6,685,249 | 8,576 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $6,233,142 | 7,547 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $4,967,048 | 6,434 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $5,430,812 | 6,130 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $5,437,712 | 6,006 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $4,446,041 | 5,715 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $3,337,799 | 5,726 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $2,981,071 | 5,550 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,226,717 | 4,748 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $1,666,273 | 4,852 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $1,773,226 | 4,847 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $1,529,445 | 4,730 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,491,782 | 4,601 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,483,396 | 5,180 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,430,819 | 5,180 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,196,839 | 5,180 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,244,227 | 5,421 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,012,751 | 5,421 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $916,970 | 5,431 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $766,891 | 5,181 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $850,616 | 5,181 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $704,697 | 5,080 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||